Skip to main content
. 2024 Apr 30;10(9):e30066. doi: 10.1016/j.heliyon.2024.e30066

Fig. 6.

Fig. 6

The distribution of expression of LINC00491, TCL6, hsa-miR-139-5p and MEX3A in different tumor stages (A) and degrees of tumor differentiation (B). DFS (C), DSS (D) and PFS (E) analysis of LINC00491, TCL6, hsa-miR-139-5p and MEX3A in HCC.